Technology, Healthcare Jan 26, 2022 08:19 PM (GMT+8) · EqualOcean
Yahuilong announced that the company, its related party Pratt Whitney Zhonglian and other investors plan to invest in Zhenxi medicine (including equity transfer and capital increase). Among them, yahuilong transferred 14.8151% equity of Zhenxi medicine with RMB 8889057 (the proportion of equity before this investment, corresponding to the registered capital of RMB 1925962), and subscribed for the new registered capital of Zhenxi medicine with RMB 5984726, with RMB 825413; Pratt Whitney Zhonglian transferred 4.9803% equity of Zhenxi medicine with RMB 2988163 (the proportion of equity before this investment, corresponding to the registered capital of RMB 647435), and subscribed for the new registered capital of Zhenxi medicine with RMB 2011834, with RMB 277472.

This text is a result of machine translation.